Viewing StudyNCT00226941



Ignite Creation Date: 2024-05-05 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00226941
Status: TERMINATED
Last Update Posted: 2017-12-08
First Post: 2005-09-08

Brief Title: A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin Capecitabine and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
Sponsor: George Albert Fisher
Organization: Stanford University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-06
Start Date Type: None
Primary Completion Date: 2008-03
Primary Completion Date Type: ACTUAL
Completion Date: 2009-02
Completion Date Type: ACTUAL
First Submit Date: 2005-09-08
First Submit QC Date: September 23 2005
Study First Post Date: 2005-09-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2017-12-08
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-11-01
Last Update Post Date: 2017-12-08
Last Update Post Date Type: ACTUAL